Trial Profile
Pharmacokinetic study of HP-3000 in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 03 Feb 2015 New trial record